open access

Vol 6, No 2 (2021)
Case report
Published online: 2021-07-01
Get Citation

Challenging multivessel percutaneous coronary intervention supported with Impella 2.5 ventricular assist device

Karolina Jasinska1, Aleksandra Gasecka1, Arkadiusz Pietrasik1, Janusz Kochman1
DOI: 10.5603/DEMJ.a2021.0016
Disaster Emerg Med J 2021;6(2):90-93.
  1. 1st Chair and Department of Cardiology, Medical University of Warsaw, Poland

open access

Vol 6, No 2 (2021)
Published online: 2021-07-01


Not available


Not available
Get Citation


Impella, PCI, MCS

About this article

Challenging multivessel percutaneous coronary intervention supported with Impella 2.5 ventricular assist device


Disaster and Emergency Medicine Journal


Vol 6, No 2 (2021)

Article type

Case report



Published online


Page views


Article views/downloads




Bibliographic record

Disaster Emerg Med J 2021;6(2):90-93.




Karolina Jasinska
Aleksandra Gasecka
Arkadiusz Pietrasik
Janusz Kochman

References (12)
  1. Left Ventricular Assist Devices. SpringerReference. .
  2. Burzotta F, Russo G, Previ L, et al. Impella: pumps overview and access site management. Minerva Cardioangiol. 2018; 66(5): 606–611.
  3. Saxena A, Garan AR, Kapur NK, et al. Partial mechanical circulatory support in an ovine model of post-infarction remodeling. J Heart Lung Transplant. 2013; 32(8): 815–822.
  4. Thiele H, Zeymer U, Neumann FJ, et al. IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367(14): 1287–1296.
  5. Bahekar A, Singh M, Singh S, et al. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis. J Cardiovasc Pharmacol Ther. 2012; 17(1): 44–56.
  6. Burzotta F, Russo G, Basile E, et al. [How to choose between intra-aortic balloon pump, Impella and extracorporeal membrane oxygenation]. G Ital Cardiol (Rome). 2018; 19(6 Suppl 1): 5S–513S.
  7. O'Neill WW, Schreiber T, Wohns DHW, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry. J Interv Cardiol. 2014; 27(1): 1–11.
  8. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008; 52(19): 1584–1588.
  9. Dangas GD, Kini AS, Sharma SK, et al. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). Am J Cardiol. 2014; 113(2): 222–228.
  10. Amin AP, Spertus JA, Curtis JP, et al. The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support. Circulation. 2020; 141(4): 273–284.
  11. Chieffo A, Ancona MB, Burzotta F, et al. Collaborators. Observational multicentre registry of patients treated with IMPella mechanical circulatory support device in ITaly: the IMP-IT registry. EuroIntervention. 2020; 15(15): e1343–e1350.
  12. Alushi B, Douedari A, Froehlig G, et al. Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. Open Heart. 2019; 6(1): e000987.


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: